Circadian Rhythm Disorders Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examine DelveInsight

Circadian Rhythm Disorders Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examine DelveInsight
Delveinsight Business Research LLP
DelveInsight’s “Circadian Rhythm Disorders Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Circadian Rhythm Disorders market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Circadian Rhythm Disorders market report covers emerging drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Circadian Rhythm Disorders Market

Circadian Rhythm Disorders: An Overview

The circadian rhythm is crucial to different physiological processes. In addition to sleep, this rhythm helps regulate body temperature, eating and digestion, and hormonal activity. The master circadian clock is found in the brain’s hypothalamus and is composed of a cluster of proteins known as the suprachiasmatic nucleus (SCN).

In a healthy adult, this clock resets – or “entrains” – every 24 h based on light and darkness cycles. A healthy person who wakes up in the morning will gradually become more tired throughout the day, and feelings of sleepiness will peak in the evening when it is dark out. A person’s sleep rhythm changes and evolves with age. This is why teenagers often go to bed later than both younger children and adults.

Circadian Rhythm Disorders Market Key Facts

  • A study by Yamadera et al. (n.d.), titled “A multicenter study of sleep-wake rhythm disorders: Clinical features of sleep-wake rhythm disorders,” reported 90 cases (74%) of DSPS and 13 cases (11%) of non-24 among 121 cases of circadian rhythm sleep disorders (CRSDs).

  • According to Kim et al., an estimated 10% of adult and 16% of adolescent sleep disorders patients may have circadian rhythm disorder (CRD).

Circadian Rhythm Disorders Market

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Circadian Rhythm Disorders market size by analyzing the impact of current and emerging pipeline therapies. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.

The report gives complete detail of the Circadian Rhythm Disorders market trend for each marketed drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MoA), Route of Administration (RoA), molecule types, competition with other therapies, brand value, and their impact on the market.

Circadian Rhythm Disorders Epidemiology Assessment 

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pool, future trends, and and views of key opinion leaders. 

Circadian Rhythm Disorders Epidemiology Segmentation

  • Total Prevalence of Circadian Rhythm Disorders

  • Type-specific Prevalence of Circadian Rhythm Disorders

  • Diagnosed and Treatable Cases of Circadian Rhythm Disorders

Circadian Rhythm Disorders Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Circadian Rhythm Disorders market or expected to get launched during the study period. The analysis covers the Circadian Rhythm Disorders market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Circadian Rhythm Disorders Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Learn How Circadian Rhythm Disorders Market Will Evolve by 2032 @

Circadian Rhythm Disorders Therapeutics Analysis

The current emerging pipeline of Circadian Rhythm Disorders (CRDs) is weak, with only few key players investing and actively working in the therapeutics market. Nevertheless, the various subtypes offer a great opportunity to develop novel therapies and capture the untapped market share. Currently, Vanda Pharmaceuticals is working on VEC-162 (HETLIOZ)  to treat Circadian Rhythm Disorders.

Vanda’s VEC-162 (HETLIOZ) is a melatonin receptor agonist indicated for treating N24HSWD. The precise mechanism by which tasimelteon exerts its therapeutic effect in patients with N24HSWD is unknown. Tasimelteon is an agonist at melatonin MT1 and MT2 receptors. These receptors are thought to be involved in the control of circadian rhythms. The asset is currently in Phase III for N24HSWD in pediatric patients and Delayed Sleep-Wake Phase Disorder (DSWPD). The company has submitted a regulatory filing for the jet lag disorder.

Further Emerging Drugs & Key Companies are Covered in the Report. Download the Sample PDF to Learn More @

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Circadian Rhythm Disorders Competitive Intelligence Analysis

4. Circadian Rhythm Disorders Market Overview at a Glance

5. Circadian Rhythm Disorders Disease Background and Overview

6. Circadian Rhythm Disorders Patient Journey

7. Circadian Rhythm Disorders Epidemiology and Patient Population (In the US, EU5, and Japan)

8. Circadian Rhythm Disorders Treatment Algorithm, Current Treatment, and Medical Practices

9. Circadian Rhythm Disorders Unmet Needs

10. Key Endpoints of Circadian Rhythm Disorders Treatment

11. Circadian Rhythm Disorders Marketed Products

12. Circadian Rhythm Disorders Emerging Drugs and Latest Therapeutic Advances

13. Circadian Rhythm Disorders Seven Major Market Analysis

14. Attribute Analysis

15. Circadian Rhythm Disorders Market Outlook (In US, EU5, and Japan)

16. Circadian Rhythm Disorders Access and Reimbursement Overview

17. KOL Views on the Circadian Rhythm Disorders Market

18. Circadian Rhythm Disorders Market Drivers

19. Circadian Rhythm Disorders Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF to Explore the Key Offerings of the Report @

Other Trending Healthcare Reports By DelveInsight

Circadian Rhythm Disorders Pipeline Insight

“Circadian Rhythm Disorders Pipeline Insights, 2022” report by DelveInsight outlays comprehensive insights into the present clinical development scenario and growth prospects across the Circadian Rhythm Disorders Market.

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States